4DX
4DMEDICAL LIMITED ORDINARY4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function imaging software; IQ-UIP, a state-of-the-art software; LDAf, Patented Parametric Response Mapping (PRM) technology; LDAi, an automated detection of potential emphysema software; LTA provides visualization and quantification of the lung textures; PHA Analysis, a cutting-edge, fully-automated imaging solution; XV LVAS, a lung airflow imaging software; and XV Scanner, a lung function scanner. The company was incorporated in 2012 and is based in Carlton, Australia.
4DX
4DX
4DMEDICAL LIMITED ORDINARY
4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging.
Fundamentals
Historical Data63 days
| Date | Short % | Gross Short |
|---|---|---|
| 16 July | — | — |
| 15 July | — | — |
| 14 July | — | — |
| 13 July | 12.00% | — |
| 10 July | 12.08% | — |
| 9 July | 11.79% | — |
| 8 July | 11.65% | — |
| 7 July | 11.29% | — |
| 6 July | 11.48% | — |
| 3 July | 11.61% | — |
| 2 July | 11.75% | — |
| 1 July | 11.60% | — |
4dmedical Limited (4DX) Short Interest Summary
4dmedical Limited (4DX) currently has 12.00% of its shares sold short (72.0 million shares, worth approximately $272.7 million), based on ASIC short position data reported on 13 July 2026 (T+4 reporting lag). That makes 4DX the #5 most shorted stock on the ASX most shorted list. Short interest in 4DX is up 0.52% over the past week and up 0.56% over the past month. 4DX is part of the Health Care sector on the ASX.
Recent 4DX Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 13 July 2026 | 12.00% | 72.0M | $3.97 |
| 10 July 2026 | 12.08% | 72.2M | $3.96 |
| 9 July 2026 | 11.79% | 70.5M | $4.06 |
| 8 July 2026 | 11.65% | 69.6M | $4.10 |
| 7 July 2026 | 11.29% | 67.5M | $4.42 |
| 6 July 2026 | 11.48% | 68.6M | $4.36 |
| 3 July 2026 | 11.61% | 69.4M | $4.25 |
| 2 July 2026 | 11.75% | 70.3M | $4.06 |
| 1 July 2026 | 11.60% | 69.3M | $4.04 |
| 30 June 2026 | 11.01% | 65.8M | $4.53 |
4DX Short Selling — Frequently Asked Questions
What is 4dmedical Limited (4DX)'s current short interest?
4dmedical Limited (4DX) currently has a short interest of 12.00% of total shares outstanding. This means 12.00% of 4DX's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is 4DX heavily shorted on the ASX?
Yes. With 12.00% of its shares sold short, 4DX is considered heavily shorted — short interest above 10% is generally regarded as high. 4DX is currently ranked #5 among the most shorted stocks on the ASX.
What does short interest mean for 4DX investors?
Short interest in 4DX shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 12.00%, 4DX's high short interest could signal strong bearish sentiment — or potential for a short squeeze if the price rises. See our short squeeze candidates and days to cover analysis for more context.
Where does this 4DX short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for 4DX.